Symbol:
Myo6
Name:
myosin VI
RGD ID:
1560646
Description:
Predicted to enable several functions, including ADP binding activity; actin filament binding activity; and calmodulin binding activity. Involved in response to xenobiotic stimulus. Located in several cellular components, including endocytic vesicle; microvillus; and ruffle membrane. Part of protein-containing complex. Used to study hypertension. Human ortholog(s) of this gene implicated in autosomal dominant nonsyndromic deafness 22; autosomal recessive nonsyndromic deafness 37; ovarian cancer; and sensorineural hearing loss. Orthologous to human MYO6 (myosin VI); PARTICIPATES IN auditory mechanotransduction pathway; E-cadherin signaling pathway; INTERACTS WITH 17beta-estradiol; 2,3,7,8-tetrachlorodibenzodioxine; 6-propyl-2-thiouracil.
Type:
protein-coding
RefSeq Status:
VALIDATED
Previously known as:
LOC315840; RGD1560646; similar to Myosin VI; unconventional myosin-VI
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Homo sapiens (human):
MYO6 (myosin VI)
HGNC
EggNOG, Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, Panther, Treefam
Mus musculus (house mouse):
Myo6 (myosin VI)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chinchilla lanigera (long-tailed chinchilla):
Myo6 (myosin VI)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Pan paniscus (bonobo/pygmy chimpanzee):
MYO6 (myosin VI)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Canis lupus familiaris (dog):
MYO6 (myosin VI)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Myo6 (myosin VI)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Sus scrofa (pig):
MYO6 (myosin VI)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chlorocebus sabaeus (green monkey):
MYO6 (myosin VI)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Heterocephalus glaber (naked mole-rat):
Myo6 (myosin VI)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Other homologs 2
Homo sapiens (human):
NUDT22 (nudix hydrolase 22)
HGNC
OMA
Alliance orthologs 3
Homo sapiens (human):
MYO6 (myosin VI)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Mus musculus (house mouse):
Myo6 (myosin VI)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|SonicParanoid)
Danio rerio (zebrafish):
myo6a (myosin VIa)
Alliance
DIOPT (Ensembl Compara|OrthoFinder|PANTHER|PhylomeDB)
Danio rerio (zebrafish):
myo6b (myosin VIb)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|SonicParanoid)
Caenorhabditis elegans (roundworm):
hum-8
Alliance
DIOPT (Hieranoid|InParanoid|OMA|OrthoFinder|PANTHER|SonicParanoid)
Drosophila melanogaster (fruit fly):
jar
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|SonicParanoid)
Caenorhabditis elegans (roundworm):
spe-15
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|PANTHER|PhylomeDB|SonicParanoid)
Xenopus tropicalis (tropical clawed frog):
myo6
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|SonicParanoid)
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 8 89,967,351 - 90,122,219 (+) NCBI GRCr8 mRatBN7.2 8 81,087,157 - 81,242,022 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 8 81,087,139 - 81,239,292 (+) Ensembl mRatBN7.2 Ensembl Rnor_6.0 8 87,583,649 - 87,731,271 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 8 87,630,916 - 87,731,269 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 8 87,121,910 - 87,268,900 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 8 85,203,987 - 85,368,026 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 Celera 8 80,810,746 - 80,962,891 (+) NCBI Celera Cytogenetic Map 8 q31 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Myo6 Rat (-)-epigallocatechin 3-gallate multiple interactions ISO MYO6 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of MYO6 mRNA CTD PMID:22079256 Myo6 Rat (1->4)-beta-D-glucan multiple interactions ISO Myo6 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of MYO6 mRNA CTD PMID:36331819 Myo6 Rat 1,2-dimethylhydrazine decreases expression ISO Myo6 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of MYO6 mRNA CTD PMID:22206623 Myo6 Rat 17beta-estradiol multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of MYO6 mRNA CTD PMID:26496021 Myo6 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Myo6 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of MYO6 mRNA CTD PMID:19770486 Myo6 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO MYO6 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in increased expression of MYO6 mRNA CTD PMID:27913140 Myo6 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Myo6 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of MYO6 mRNA CTD PMID:27913140 Myo6 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of MYO6 mRNA CTD PMID:27913140 and PMID:34747641 Myo6 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Myo6 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of MYO6 mRNA CTD PMID:26377647 Myo6 Rat 2-hydroxypropanoic acid decreases expression ISO MYO6 (Homo sapiens) 6480464 Lactic Acid results in decreased expression of MYO6 mRNA CTD PMID:30851411 Myo6 Rat 4-hydroxyphenyl retinamide increases expression ISO Myo6 (Mus musculus) 6480464 Fenretinide results in increased expression of MYO6 mRNA CTD PMID:28973697 Myo6 Rat 5-fluorouracil affects response to substance ISO MYO6 (Homo sapiens) 6480464 MYO6 protein affects the susceptibility to Fluorouracil CTD PMID:16217747 Myo6 Rat 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of MYO6 mRNA CTD PMID:24780913 Myo6 Rat acetaldehyde affects expression ISO Myo6 (Mus musculus) 6480464 Acetaldehyde affects the expression of MYO6 mRNA CTD PMID:22634333 Myo6 Rat aflatoxin B1 increases expression ISO MYO6 (Homo sapiens) 6480464 Aflatoxin B1 results in increased expression of MYO6 mRNA CTD PMID:21641981 Myo6 Rat all-trans-retinoic acid increases expression ISO MYO6 (Homo sapiens) 6480464 Tretinoin results in increased expression of MYO6 mRNA CTD PMID:21934132 Myo6 Rat arsenous acid increases expression ISO MYO6 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of MYO6 mRNA CTD PMID:17258074 Myo6 Rat benzo[a]pyrene increases expression ISO MYO6 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of MYO6 mRNA CTD PMID:21632981 and PMID:26238291 Myo6 Rat benzo[a]pyrene increases methylation ISO MYO6 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of MYO6 promoter CTD PMID:27901495 Myo6 Rat bicalutamide increases expression ISO MYO6 (Homo sapiens) 6480464 bicalutamide results in increased expression of MYO6 mRNA CTD PMID:15790403 and PMID:16631469 Myo6 Rat bis(2-chloroethyl) sulfide increases expression ISO MYO6 (Homo sapiens) 6480464 Mustard Gas results in increased expression of MYO6 mRNA CTD PMID:25102026 Myo6 Rat bisphenol A increases expression ISO Myo6 (Mus musculus) 6480464 bisphenol A results in increased expression of MYO6 mRNA CTD PMID:26063408 and PMID:34585602 Myo6 Rat bisphenol A increases expression ISO MYO6 (Homo sapiens) 6480464 bisphenol A results in increased expression of MYO6 protein CTD PMID:37567409 Myo6 Rat bisphenol A decreases expression ISO Myo6 (Mus musculus) 6480464 bisphenol A results in decreased expression of MYO6 mRNA CTD PMID:33221593 Myo6 Rat bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of MYO6 mRNA CTD PMID:25181051 and PMID:30816183 Myo6 Rat bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of MYO6 mRNA CTD PMID:26496021 Myo6 Rat bisphenol AF increases expression ISO MYO6 (Homo sapiens) 6480464 bisphenol AF results in increased expression of MYO6 protein CTD PMID:34186270 Myo6 Rat Bisphenol B increases expression ISO MYO6 (Homo sapiens) 6480464 bisphenol B results in increased expression of MYO6 protein CTD PMID:34186270 Myo6 Rat bisphenol F increases expression ISO MYO6 (Homo sapiens) 6480464 bisphenol F results in increased expression of MYO6 protein CTD PMID:34186270 Myo6 Rat cadmium dichloride increases expression ISO MYO6 (Homo sapiens) 6480464 Cadmium Chloride results in increased expression of MYO6 mRNA CTD PMID:26472689 Myo6 Rat caffeine affects phosphorylation ISO MYO6 (Homo sapiens) 6480464 Caffeine affects the phosphorylation of MYO6 protein CTD PMID:35688186 Myo6 Rat carbamazepine affects expression ISO Myo6 (Mus musculus) 6480464 Carbamazepine affects the expression of MYO6 mRNA CTD PMID:22634333 Myo6 Rat choline multiple interactions ISO Myo6 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of MYO6 mRNA CTD PMID:20938992 Myo6 Rat cisplatin multiple interactions ISO Myo6 (Mus musculus) 6480464 [Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in decreased expression of MYO6 mRNA CTD PMID:23625948 Myo6 Rat cisplatin increases expression ISO MYO6 (Homo sapiens) 6480464 Cisplatin results in increased expression of MYO6 mRNA CTD PMID:27392435 Myo6 Rat cisplatin multiple interactions ISO MYO6 (Homo sapiens) 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of MYO6 mRNA CTD PMID:27392435 Myo6 Rat clorgyline increases expression ISO MYO6 (Homo sapiens) 6480464 Clorgyline results in increased expression of MYO6 mRNA CTD PMID:19691856 Myo6 Rat cobalt dichloride increases expression ISO MYO6 (Homo sapiens) 6480464 cobaltous chloride results in increased expression of MYO6 mRNA CTD PMID:19376846 Myo6 Rat coumestrol multiple interactions ISO MYO6 (Homo sapiens) 6480464 [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MYO6 mRNA CTD PMID:19167446 Myo6 Rat coumestrol decreases expression ISO MYO6 (Homo sapiens) 6480464 Coumestrol results in decreased expression of MYO6 mRNA CTD PMID:19167446 Myo6 Rat cyclosporin A decreases expression ISO Myo6 (Mus musculus) 6480464 Cyclosporine results in decreased expression of MYO6 mRNA CTD PMID:19770486 Myo6 Rat cyproconazole increases expression ISO Myo6 (Mus musculus) 6480464 cyproconazole results in increased expression of MYO6 mRNA CTD PMID:22045034 Myo6 Rat diarsenic trioxide increases expression ISO MYO6 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of MYO6 mRNA CTD PMID:17258074 Myo6 Rat dioxygen multiple interactions ISO Myo6 (Mus musculus) 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MYO6 mRNA CTD PMID:30529165 Myo6 Rat doxorubicin decreases expression ISO MYO6 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of MYO6 mRNA CTD PMID:29803840 Myo6 Rat elemental selenium multiple interactions ISO MYO6 (Homo sapiens) 6480464 [Selenium co-treated with Vitamin E] results in decreased expression of MYO6 mRNA CTD PMID:19244175 Myo6 Rat elemental selenium decreases expression ISO MYO6 (Homo sapiens) 6480464 Selenium results in decreased expression of MYO6 mRNA CTD PMID:19244175 Myo6 Rat endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of MYO6 mRNA CTD PMID:29391264 Myo6 Rat Enterolactone multiple interactions ISO MYO6 (Homo sapiens) 6480464 [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MYO6 mRNA CTD PMID:19167446 Myo6 Rat ethanol increases expression ISO Myo6 (Mus musculus) 6480464 Ethanol results in increased expression of MYO6 mRNA CTD PMID:30319688 Myo6 Rat ethanol affects splicing ISO Myo6 (Mus musculus) 6480464 Ethanol affects the splicing of MYO6 mRNA CTD PMID:30319688 Myo6 Rat ethyl methanesulfonate increases expression ISO MYO6 (Homo sapiens) 6480464 Ethyl Methanesulfonate results in increased expression of MYO6 mRNA CTD PMID:23649840 Myo6 Rat flusilazole affects expression ISO Myo6 (Mus musculus) 6480464 flusilazole affects the expression of MYO6 mRNA CTD PMID:22634333 Myo6 Rat folic acid multiple interactions ISO Myo6 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of MYO6 mRNA CTD PMID:20938992 Myo6 Rat formaldehyde increases expression ISO MYO6 (Homo sapiens) 6480464 Formaldehyde results in increased expression of MYO6 mRNA CTD PMID:23649840 Myo6 Rat furfural multiple interactions ISO MYO6 (Homo sapiens) 6480464 [Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of MYO6 protein CTD PMID:38598786 Myo6 Rat gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of MYO6 mRNA CTD PMID:33387578 Myo6 Rat geraniol increases expression ISO MYO6 (Homo sapiens) 6480464 geraniol results in increased expression of MYO6 mRNA CTD PMID:27683099 Myo6 Rat glyphosate affects methylation EXP 6480464 Glyphosate affects the methylation of MYO6 gene CTD PMID:35440735 Myo6 Rat hexaconazole increases expression ISO Myo6 (Mus musculus) 6480464 hexaconazole results in increased expression of MYO6 mRNA CTD PMID:22045034 Myo6 Rat ivermectin decreases expression ISO MYO6 (Homo sapiens) 6480464 Ivermectin results in decreased expression of MYO6 protein CTD PMID:32959892 Myo6 Rat L-methionine multiple interactions ISO Myo6 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of MYO6 mRNA CTD PMID:20938992 Myo6 Rat lead diacetate decreases expression ISO Myo6 (Mus musculus) 6480464 lead acetate results in decreased expression of MYO6 mRNA CTD PMID:21829687 Myo6 Rat manganese atom multiple interactions ISO MYO6 (Homo sapiens) 6480464 [manganese chloride results in increased abundance of Manganese] which results in increased expression of MYO6 mRNA CTD PMID:39836092 Myo6 Rat manganese(0) multiple interactions ISO MYO6 (Homo sapiens) 6480464 [manganese chloride results in increased abundance of Manganese] which results in increased expression of MYO6 mRNA CTD PMID:39836092 Myo6 Rat manganese(II) chloride multiple interactions ISO MYO6 (Homo sapiens) 6480464 [manganese chloride results in increased abundance of Manganese] which results in increased expression of MYO6 mRNA CTD PMID:39836092 Myo6 Rat methotrexate affects response to substance ISO MYO6 (Homo sapiens) 6480464 MYO6 protein affects the susceptibility to Methotrexate CTD PMID:16217747 Myo6 Rat methoxychlor affects methylation EXP 6480464 Methoxychlor affects the methylation of MYO6 gene CTD PMID:35440735 Myo6 Rat methyl methanesulfonate increases expression ISO MYO6 (Homo sapiens) 6480464 Methyl Methanesulfonate results in increased expression of MYO6 mRNA CTD PMID:23649840 Myo6 Rat mono(2-ethylhexyl) phthalate decreases expression ISO MYO6 (Homo sapiens) 6480464 mono-(2-ethylhexyl)phthalate results in decreased expression of MYO6 mRNA CTD PMID:36314267 and PMID:38685446 Myo6 Rat N,N-diethyl-m-toluamide multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in increased methylation of MYO6 gene CTD PMID:33148267 Myo6 Rat N-ethyl-N-nitrosourea increases mutagenesis ISO Myo6 (Mus musculus) 6480464 Ethylnitrosourea results in increased mutagenesis of MYO6 gene CTD PMID:17329413 Myo6 Rat ozone multiple interactions ISO Myo6 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of MYO6 mRNA CTD PMID:34911549 Myo6 Rat paracetamol increases expression ISO MYO6 (Homo sapiens) 6480464 Acetaminophen results in increased expression of MYO6 mRNA CTD PMID:22230336 Myo6 Rat paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of MYO6 mRNA CTD PMID:33387578 Myo6 Rat perfluorooctane-1-sulfonic acid multiple interactions ISO Myo6 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of MYO6 mRNA CTD PMID:36331819 Myo6 Rat permethrin multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in increased methylation of MYO6 gene CTD PMID:33148267 Myo6 Rat potassium chromate decreases expression ISO MYO6 (Homo sapiens) 6480464 potassium chromate(VI) results in decreased expression of MYO6 mRNA CTD PMID:22079256 Myo6 Rat potassium chromate multiple interactions ISO MYO6 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of MYO6 mRNA CTD PMID:22079256 Myo6 Rat quercetin affects expression ISO MYO6 (Homo sapiens) 6480464 Quercetin affects the expression of MYO6 mRNA CTD PMID:21632981 Myo6 Rat rac-lactic acid decreases expression ISO MYO6 (Homo sapiens) 6480464 Lactic Acid results in decreased expression of MYO6 mRNA CTD PMID:30851411 Myo6 Rat SB 431542 multiple interactions ISO MYO6 (Homo sapiens) 6480464 [LDN 193189 co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of MYO6 protein CTD PMID:37664457 Myo6 Rat selenium atom multiple interactions ISO MYO6 (Homo sapiens) 6480464 [Selenium co-treated with Vitamin E] results in decreased expression of MYO6 mRNA CTD PMID:19244175 Myo6 Rat selenium atom decreases expression ISO MYO6 (Homo sapiens) 6480464 Selenium results in decreased expression of MYO6 mRNA CTD PMID:19244175 Myo6 Rat sodium arsenite decreases expression ISO Myo6 (Mus musculus) 6480464 sodium arsenite results in decreased expression of MYO6 mRNA CTD PMID:37682722 Myo6 Rat sodium chloride multiple interactions ISO MYO6 (Homo sapiens) 6480464 [Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of MYO6 protein CTD PMID:38598786 Myo6 Rat sunitinib increases expression ISO MYO6 (Homo sapiens) 6480464 Sunitinib results in increased expression of MYO6 mRNA CTD PMID:31533062 Myo6 Rat temozolomide increases expression ISO MYO6 (Homo sapiens) 6480464 Temozolomide results in increased expression of MYO6 mRNA CTD PMID:31758290 Myo6 Rat thimerosal decreases expression ISO MYO6 (Homo sapiens) 6480464 Thimerosal results in decreased expression of MYO6 mRNA CTD PMID:27188386 Myo6 Rat thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of MYO6 mRNA CTD PMID:23411599 Myo6 Rat titanium dioxide decreases methylation ISO Myo6 (Mus musculus) 6480464 titanium dioxide results in decreased methylation of MYO6 gene CTD PMID:35295148 Myo6 Rat torcetrapib increases expression ISO MYO6 (Homo sapiens) 6480464 torcetrapib results in increased expression of MYO6 mRNA CTD PMID:23228038 Myo6 Rat triphenyl phosphate affects expression ISO MYO6 (Homo sapiens) 6480464 triphenyl phosphate affects the expression of MYO6 mRNA CTD PMID:37042841 Myo6 Rat urethane increases expression ISO MYO6 (Homo sapiens) 6480464 Urethane results in increased expression of MYO6 mRNA CTD PMID:28818685 Myo6 Rat valproic acid increases expression ISO Myo6 (Mus musculus) 6480464 Valproic Acid results in increased expression of MYO6 mRNA CTD PMID:22045034 Myo6 Rat valproic acid affects splicing EXP 6480464 Valproic Acid affects the splicing of MYO6 mRNA CTD PMID:29427782 Myo6 Rat valproic acid increases expression ISO MYO6 (Homo sapiens) 6480464 Valproic Acid results in increased expression of MYO6 mRNA CTD PMID:19101580 more ... Myo6 Rat valproic acid affects expression ISO MYO6 (Homo sapiens) 6480464 Valproic Acid affects the expression of MYO6 mRNA CTD PMID:25979313 Myo6 Rat vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of MYO6 mRNA CTD PMID:23034163 Myo6 Rat vitamin E decreases expression ISO MYO6 (Homo sapiens) 6480464 Vitamin E results in decreased expression of MYO6 mRNA CTD PMID:19244175 Myo6 Rat vitamin E multiple interactions ISO MYO6 (Homo sapiens) 6480464 [Selenium co-treated with Vitamin E] results in decreased expression of MYO6 mRNA CTD PMID:19244175
Imported Annotations - PID (archival)
Cellular Component
actin cytoskeleton (IBA,IEA) actin filament (ISO) apical part of cell (IDA) axon (ISO) brush border (ISO) cell cortex (ISO) clathrin-coated endocytic vesicle (IEA,ISO) clathrin-coated pit (ISO) cochlear hair cell ribbon synapse (ISO) cytoplasm (IBA,IEA,ISO) cytoplasmic vesicle (IDA,IEA,ISO) endocytic vesicle (IBA,IDA,ISO) filamentous actin (IEA,ISO) glutamatergic synapse (ISO) Golgi apparatus (IDA,IEA,ISO) microvillus (IDA,IEA) myosin complex (IEA) neuronal cell body (ISO) nuclear membrane (IEA,ISO) nucleoplasm (IEA,ISO) nucleus (IEA,ISO) perinuclear region of cytoplasm (IEA,ISO) plasma membrane (IBA,ISO) postsynaptic actin cytoskeleton (ISO) postsynaptic density (ISO) presynaptic endocytic zone (ISO) protein-containing complex (IDA) ruffle (IBA,IEA,ISO) ruffle membrane (IDA,IEA) Schaffer collateral - CA1 synapse (ISO) vesicle membrane (ISO)
1.
Expression of myosin VI within the early endocytic pathway in adult and developing proximal tubules.
Biemesderfer D, etal., Am J Physiol Renal Physiol. 2002 May;282(5):F785-94.
2.
The localization of myosin VI at the golgi complex and leading edge of fibroblasts and its phosphorylation and recruitment into membrane ruffles of A431 cells after growth factor stimulation.
Buss F, etal., J Cell Biol. 1998 Dec 14;143(6):1535-45.
3.
Regulation of myosin-VI targeting to endocytic compartments.
Dance AL, etal., Traffic. 2004 Oct;5(10):798-813.
4.
Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.
Gaudet P, etal., Brief Bioinform. 2011 Sep;12(5):449-62. doi: 10.1093/bib/bbr042. Epub 2011 Aug 27.
5.
Myosin VI in the nucleus of neurosecretory PC12 cells: Stimulation-dependent nuclear translocation and interaction with nuclear proteins.
Majewski L, etal., Nucleus. 2018 Jan 1;9(1):125-141. doi: 10.1080/19491034.2017.1421881.
6.
MYO6, the human homologue of the gene responsible for deafness in Snell's waltzer mice, is mutated in autosomal dominant nonsyndromic hearing loss.
Melchionda S, etal., Am J Hum Genet. 2001 Sep;69(3):635-40. Epub 2001 Jul 20.
7.
OMIM Disease Annotation Pipeline
OMIM Disease Annotation Pipeline
8.
PID Annotation Import Pipeline
Pipeline to import Pathway Interaction Database annotations from NCI into RGD
9.
GOA pipeline
RGD automated data pipeline
10.
ClinVar Automated Import and Annotation Pipeline
RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
11.
Data Import for Chemical-Gene Interactions
RGD automated import pipeline for gene-chemical interactions
12.
Comprehensive gene review and curation
RGD comprehensive gene curation
13.
The auditory hair cell ribbon synapse: from assembly to function.
Safieddine S, etal., Annu Rev Neurosci. 2012;35:509-28. doi: 10.1146/annurev-neuro-061010-113705.
14.
Optineurin links myosin VI to the Golgi complex and is involved in Golgi organization and exocytosis.
Sahlender DA, etal., J Cell Biol. 2005 Apr 25;169(2):285-95. Epub 2005 Apr 18.
15.
Review series: The cell biology of hearing.
Schwander M, etal., J Cell Biol. 2010 Jul 12;190(1):9-20. doi: 10.1083/jcb.201001138.
16.
Pdlim2, a novel PDZ-LIM domain protein, interacts with alpha-actinins and filamin A.
Torrado M, etal., Invest Ophthalmol Vis Sci 2004 Nov;45(11):3955-63.
17.
GOLPH2 and MYO6: putative prostate cancer markers localized to the Golgi apparatus.
Wei S, etal., Prostate. 2008 Sep 15;68(13):1387-95.
18.
Interaction of SAP97 with Minus-end-directed Actin Motor Myosin VI. IMPLICATIONS FOR AMPA RECEPTOR TRAFFICKING.
Wu H, etal., J Biol Chem 2002 Aug 23;277(34):30928-34.
19.
Reducing blood pressure in SHR with enalapril provokes redistribution of NHE3, NaPi2, and NCC and decreases NaPi2 and ACE abundance.
Yang LE, etal., Am J Physiol Renal Physiol. 2007 Oct;293(4):F1197-208. Epub 2007 Jul 25.
20.
Effects of dietary salt on renal Na+ transporter subcellular distribution, abundance, and phosphorylation status.
Yang LE, etal., Am J Physiol Renal Physiol. 2008 Oct;295(4):F1003-16. Epub 2008 Jul 23.
21.
Redistribution of myosin VI from top to base of proximal tubule microvilli during acute hypertension.
Yang LE, etal., J Am Soc Nephrol. 2005 Oct;16(10):2890-6. Epub 2005 Aug 17.
22.
Lessons from border cell migration in the Drosophila ovary: A role for myosin VI in dissemination of human ovarian cancer.
Yoshida H, etal., Proc Natl Acad Sci U S A. 2004 May 25;101(21):8144-9. Epub 2004 May 14.
Myo6 (Rattus norvegicus - Norway rat)
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 8 89,967,351 - 90,122,219 (+) NCBI GRCr8 mRatBN7.2 8 81,087,157 - 81,242,022 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 8 81,087,139 - 81,239,292 (+) Ensembl mRatBN7.2 Ensembl Rnor_6.0 8 87,583,649 - 87,731,271 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 8 87,630,916 - 87,731,269 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 8 87,121,910 - 87,268,900 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 8 85,203,987 - 85,368,026 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 Celera 8 80,810,746 - 80,962,891 (+) NCBI Celera Cytogenetic Map 8 q31 NCBI
MYO6 (Homo sapiens - human)
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 6 75,749,239 - 75,919,537 (+) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 6 75,749,201 - 75,919,537 (+) Ensembl GRCh38 hg38 GRCh38 GRCh37 6 76,458,956 - 76,629,254 (+) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 6 76,515,629 - 76,685,974 (+) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 6 76,515,702 - 76,682,665 NCBI Celera 6 76,852,216 - 77,022,585 (+) NCBI Celera Cytogenetic Map 6 q14.1 NCBI HuRef 6 73,657,457 - 73,828,024 (+) NCBI HuRef CHM1_1 6 76,625,146 - 76,795,504 (+) NCBI CHM1_1 T2T-CHM13v2.0 6 76,926,117 - 77,096,418 (+) NCBI T2T-CHM13v2.0
Myo6 (Mus musculus - house mouse)
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 9 80,072,262 - 80,219,011 (+) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 9 80,072,313 - 80,219,011 (+) Ensembl GRCm39 Ensembl GRCm38 9 80,164,976 - 80,311,729 (+) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 9 80,165,031 - 80,311,729 (+) Ensembl GRCm38 mm10 GRCm38 MGSCv37 9 80,012,841 - 80,159,536 (+) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 9 79,950,724 - 80,097,413 (+) NCBI MGSCv36 mm8 Celera 9 77,304,677 - 77,455,393 (+) NCBI Celera Cytogenetic Map 9 E1 NCBI cM Map 9 43.98 NCBI
Myo6 (Chinchilla lanigera - long-tailed chinchilla)
Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955502 4,218,885 - 4,356,988 (+) Ensembl ChiLan1.0 ChiLan1.0 NW_004955502 4,219,067 - 4,356,988 (+) NCBI ChiLan1.0 ChiLan1.0
MYO6 (Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 5 95,797,543 - 95,965,239 (+) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 6 93,675,327 - 93,845,906 (+) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 6 73,593,794 - 73,764,352 (+) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 6 76,882,994 - 77,050,015 (+) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 6 76,951,634 - 77,048,796 (+) Ensembl panpan1.1 panPan2
MYO6 (Canis lupus familiaris - dog)
Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 12 37,359,200 - 37,502,342 (+) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 12 37,413,570 - 37,500,724 (+) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 12 37,238,751 - 37,384,310 (+) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 12 38,063,158 - 38,289,614 (+) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 12 38,063,189 - 38,287,255 (+) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 12 37,466,515 - 37,612,373 (+) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 12 37,455,898 - 37,602,259 (+) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 12 37,586,007 - 37,731,589 (+) NCBI UU_Cfam_GSD_1.0
Myo6 (Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl HiC_Itri_2 NW_024404946 72,743,121 - 72,882,178 (+) NCBI HiC_Itri_2 SpeTri2.0 Ensembl NW_004936788 1,174,544 - 1,262,746 (+) Ensembl SpeTri2.0 SpeTri2.0 Ensembl SpeTri2.0 NW_004936788 1,125,332 - 1,264,372 (+) NCBI SpeTri2.0 SpeTri2.0 SpeTri2.0
MYO6 (Sus scrofa - pig)
Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 1 89,992,866 - 90,137,734 (-) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 1 89,992,860 - 90,137,767 (-) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 1 100,972,527 - 101,143,888 (-) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
MYO6 (Chlorocebus sabaeus - green monkey)
Myo6 (Heterocephalus glaber - naked mole-rat)
.
Predicted Target Of
Count of predictions: 250 Count of miRNA genes: 109 Interacting mature miRNAs: 116 Transcripts: ENSRNOT00000016428, ENSRNOT00000064856 Prediction methods: Microtar, Miranda, Rnahybrid, Targetscan Result types: miRGate_prediction
1554321 Bmd3 Bone mineral density QTL 3 7.9 0.0001 femur mineral mass (VT:0010011) volumetric bone mineral density (CMO:0001553) 8 40952565 123900184 Rat 9590292 Uminl3 Urine mineral level QTL 3 3.62 0.001 urine mineral amount (VT:0015086) urine electrolyte level (CMO:0000593) 8 71888757 116888757 Rat 1578769 Uae31 Urinary albumin excretion QTL 31 3.3 0.001 urine albumin amount (VT:0002871) urine albumin excretion rate (CMO:0000757) 8 30848154 101699754 Rat 1298079 Activ2 Activity QTL 2 9.5 0.000001 voluntary movement trait (VT:0003491) rearing measurement (CMO:0001515) 8 41866876 86866876 Rat 70161 Bp62 Blood pressure QTL 62 2.9 0.001 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 8 42692684 90165460 Rat 1578765 Klgr1 Kidney lesion grade QTL 1 3.3 0.0001 kidney morphology trait (VT:0002135) organ lesion measurement (CMO:0000677) 8 30848154 101699754 Rat 4889938 Bss89 Bone structure and strength QTL 89 3.8 tibia size trait (VT:0100001) tibia cortical bone volume (CMO:0001725) 8 50095249 82460899 Rat 1578755 Pur5 Proteinuria QTL 5 3.3 0.0001 urine total protein amount (VT:0000032) urine total protein excretion rate (CMO:0000756) 8 30848154 101699754 Rat 8662823 Vetf5 Vascular elastic tissue fragility QTL 5 1.9 artery integrity trait (VT:0010639) patent ductus arteriosus score (CMO:0002566) 8 28242912 99525068 Rat 2313088 Bss75 Bone structure and strength QTL 75 3.1 0.0001 body length (VT:0001256) body length, nose to rump (CMO:0000079) 8 30848154 82460899 Rat 631210 Bw3 Body weight QTL3 5.9 mesenteric fat pad mass (VT:0010427) mesenteric fat pad weight to body weight ratio (CMO:0000654) 8 69349194 112783834 Rat 1358896 Bp262 Blood pressure QTL 262 2.89 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 8 27205715 99103503 Rat 731182 Uae24 Urinary albumin excretion QTL 24 6.4 urine albumin amount (VT:0002871) urine albumin excretion rate (CMO:0000757) 8 19331152 93965294 Rat 8694446 Bw170 Body weight QTL 170 12.07 0.001 retroperitoneal fat pad mass (VT:0010430) retroperitoneal fat pad weight to body weight ratio (CMO:0000635) 8 71888757 116888757 Rat 737824 Hcar10 Hepatocarcinoma resistance QTL 10 2.9 liver integrity trait (VT:0010547) liver tumorous lesion number (CMO:0001068) 8 40713066 82925667 Rat 1358906 Bp253 Blood pressure QTL 253 4 0.0004 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 8 40713066 93965294 Rat 10450865 Bw175 Body weight QTL 175 4.1 total fat pad mass (VT:0015008) adipose tissue molecular composition measurement (CMO:0000484) 8 75311777 84531599 Rat 1358907 Cm40 Cardiac mass QTL 40 1.89 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 8 27205715 99103503 Rat 70197 BpQTLcluster8 Blood pressure QTL cluster 8 3.482 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 8 46531639 119088626 Rat 2316950 Scl66 Serum cholesterol level QTL 66 4.1 blood cholesterol amount (VT:0000180) plasma total cholesterol level (CMO:0000585) 8 30848259 105647037 Rat 1582254 Kidm31 Kidney mass QTL 31 3 kidney mass (VT:0002707) both kidneys wet weight (CMO:0000085) 8 54237644 85365202 Rat 2300181 Bmd55 Bone mineral density QTL 55 5.7 0.0001 femur mineral mass (VT:0010011) volumetric bone mineral density (CMO:0001553) 8 76468691 121468691 Rat 10402857 Bp380 Blood pressure QTL 380 0.95 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 8 53968765 98968765 Rat 1358892 Kidm26 Kidney mass QTL 26 3.69 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 8 27205715 99103503 Rat 5684973 Bss100 Bone structure and strength QTL 100 4.7 tibia area (VT:1000281) tibia area measurement (CMO:0001382) 8 50095249 82460899 Rat 1582243 Bw66 Body weight QTL 66 3.4 0.0048 body mass (VT:0001259) body weight (CMO:0000012) 8 54237644 85365202 Rat 8694200 Abfw4 Abdominal fat weight QTL 4 9.07 0.001 visceral adipose mass (VT:0010063) abdominal fat pad weight to body weight ratio (CMO:0000095) 8 71888757 116888757 Rat 2313057 Bss76 Bone structure and strength QTL 76 3 0.0001 tibia size trait (VT:0100001) tibia midshaft cross-sectional area (CMO:0001717) 8 30848154 82460899 Rat 12879878 Bw183 Body weight QTL 183 0.001 body mass (VT:0001259) body weight (CMO:0000012) 8 43296169 98968765 Rat 1300177 Cm2 Cardiac mass QTL 2 3.65 heart mass (VT:0007028) heart weight (CMO:0000017) 8 54259986 100382532 Rat 1549909 Stresp11 Stress response QTL 11 6.83 0.0019 stress-related behavior trait (VT:0010451) number of approaches toward negative stimulus before onset of defensive burying response (CMO:0001960) 8 73473045 118473045 Rat 1549908 Neudeg1 Neurodegradation QTL 1 5.5 0 nervous system integrity trait (VT:0010566) logarithm of the ratio of the lesioned side motor neuron count to contralateral side motor neuron count (CMO:0001986) 8 30188867 94457446 Rat 12879879 Cm99 Cardiac mass QTL 99 0.001 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 8 43296169 98968765 Rat 2313067 Bss77 Bone structure and strength QTL 77 3.1 0.0001 tibia size trait (VT:0100001) tibia midshaft endosteal cross-sectional area (CMO:0001716) 8 30848154 82460899 Rat 12879880 Cm100 Cardiac mass QTL 100 0.001 heart left ventricle mass (VT:0007031) heart left ventricle weight to body weight ratio (CMO:0000530) 8 43296169 98968765 Rat 12879881 Cm101 Cardiac mass QTL 101 0.001 heart right ventricle mass (VT:0007033) heart right ventricle weight to body weight ratio (CMO:0000914) 8 43296169 98968765 Rat 12879882 Am8 Aortic mass QTL 8 0.001 aorta mass (VT:0002845) aorta weight to aorta length to body weight ratio (CMO:0002722) 8 43296169 98968765 Rat 12879883 Kidm65 Kidney mass QTL 65 0.001 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 8 43296169 98968765 Rat 1358912 Bw51 Body weight QTL 51 2.95 body mass (VT:0001259) body weight (CMO:0000012) 8 51351728 107062046 Rat 634332 Pia18 Pristane induced arthritis QTL 18 4 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 8 75311938 82925521 Rat 1300171 Bp184 Blood pressure QTL 184 3.66 arterial blood pressure trait (VT:2000000) blood pressure time series experimental set point of the baroreceptor response (CMO:0002593) 8 70513503 118219066 Rat 2313086 Bss60 Bone structure and strength QTL 60 4.1 0.0001 tibia length (VT:0004357) tibia length (CMO:0000450) 8 50095249 82460899 Rat 2303171 Bp331 Blood pressure QTL 331 5.57 0.005 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 8 61290298 119084929 Rat 2293697 Bmd39 Bone mineral density QTL 39 femur strength trait (VT:0010010) femur total energy absorbed before break (CMO:0001677) 8 54043744 98968765 Rat 1331837 Bw23 Body weight QTL 23 4.19 0.00007 body mass (VT:0001259) body weight (CMO:0000012) 8 46531722 99083736 Rat 1331838 Niddm61 Non-insulin dependent diabetes mellitus QTL 61 3.53 0.0004 blood insulin amount (VT:0001560) plasma insulin level (CMO:0000342) 8 36469535 99083736 Rat 631650 Stl6 Serum triglyceride level QTL 6 4 0.0019 blood triglyceride amount (VT:0002644) plasma triglyceride level (CMO:0000548) 8 10378157 112202585 Rat 11528644 Bss115 Bone structure and strength QTL 115 6.56 3e-07 femur morphology trait (VT:0000559) femur head width (CMO:0002717) 8 80802332 81664473 Rat 631653 Bp125 Blood pressure QTL 125 3.3 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 8 66142385 111142385 Rat 1581557 Eae16 Experimental allergic encephalomyelitis QTL 16 3.8 nervous system integrity trait (VT:0010566) experimental autoimmune encephalomyelitis incidence/prevalence measurement (CMO:0001046) 8 8462195 110921472 Rat 631271 Lecl1 Lens clarity QTL 1 0.001 lens clarity trait (VT:0001304) age of onset/diagnosis of cataract (CMO:0001584) 8 18984168 84531599 Rat 2303570 Gluco48 Glucose level QTL 48 2 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 8 49805831 94805831 Rat 2313046 Bss78 Bone structure and strength QTL 78 3.5 0.0001 tibia strength trait (VT:1000284) tibia total energy absorbed before break (CMO:0001736) 8 30848154 82460899 Rat 2301402 Bp316 Blood pressure QTL 316 0.005 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 8 53968765 98968765 Rat 631664 Hcar3 Hepatocarcinoma resistance QTL 3 2.9 0.0005 liver integrity trait (VT:0010547) volume of individual liver tumorous lesion (CMO:0001078) 8 54237644 99103503 Rat 8694392 Bw161 Body weight QTL 161 8.06 0.001 body lean mass (VT:0010483) lean tissue morphological measurement (CMO:0002184) 8 71888757 116888757 Rat
RH133282
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 8 81,239,463 - 81,239,648 (+) MAPPER mRatBN7.2 Rnor_6.0 8 87,728,711 - 87,728,895 NCBI Rnor6.0 Rnor_5.0 8 87,266,340 - 87,266,524 UniSTS Rnor5.0 RGSC_v3.4 8 85,367,836 - 85,368,020 UniSTS RGSC3.4 Celera 8 80,960,331 - 80,960,515 UniSTS RH 3.4 Map 8 930.3 UniSTS Cytogenetic Map 8 q31 UniSTS
U49739
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 8 81,238,156 - 81,238,344 (+) MAPPER mRatBN7.2 Rnor_6.0 8 87,727,404 - 87,727,591 NCBI Rnor6.0 Rnor_5.0 8 87,265,033 - 87,265,220 UniSTS Rnor5.0 RGSC_v3.4 8 85,366,529 - 85,366,716 UniSTS RGSC3.4 Celera 8 80,959,024 - 80,959,211 UniSTS Cytogenetic Map 8 q31 UniSTS
BF399451
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 8 81,093,922 - 81,094,110 (+) MAPPER mRatBN7.2 Rnor_6.0 8 87,590,409 - 87,590,596 NCBI Rnor6.0 Rnor_5.0 8 87,128,666 - 87,128,853 UniSTS Rnor5.0 RGSC_v3.4 8 85,210,706 - 85,210,893 UniSTS RGSC3.4 Celera 8 80,817,378 - 80,817,565 UniSTS RH 3.4 Map 8 933.5 UniSTS Cytogenetic Map 8 q31 UniSTS
AU048109
Rat Assembly Chr Position (strand) Source JBrowse Celera 8 80,871,294 - 80,871,470 UniSTS Cytogenetic Map 8 q31 UniSTS
PMC124268P1
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 8 81,237,301 - 81,238,188 (+) MAPPER mRatBN7.2 Rnor_6.0 8 87,726,549 - 87,727,435 NCBI Rnor6.0 Rnor_5.0 8 87,264,178 - 87,265,064 UniSTS Rnor5.0 RGSC_v3.4 8 85,365,674 - 85,366,560 UniSTS RGSC3.4 Celera 8 80,958,169 - 80,959,055 UniSTS Cytogenetic Map 8 q31 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
9
11
49
113
91
90
59
25
59
6
218
97
93
45
60
31
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000016428 ⟹ ENSRNOP00000016428
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 8 81,087,139 - 81,239,292 (+) Ensembl Rnor_6.0 Ensembl 8 87,630,916 - 87,731,269 (+) Ensembl
Ensembl Acc Id:
ENSRNOT00000103299 ⟹ ENSRNOP00000091730
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 8 81,087,139 - 81,239,292 (+) Ensembl
Ensembl Acc Id:
ENSRNOT00000108142 ⟹ ENSRNOP00000091239
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 8 81,087,139 - 81,239,292 (+) Ensembl
Ensembl Acc Id:
ENSRNOT00000112254 ⟹ ENSRNOP00000077341
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 8 81,087,139 - 81,239,292 (+) Ensembl
Ensembl Acc Id:
ENSRNOT00000119730 ⟹ ENSRNOP00000083145
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 8 81,087,139 - 81,239,292 (+) Ensembl
Ensembl Acc Id:
ENSRNOT00000120263 ⟹ ENSRNOP00000083134
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 8 81,087,139 - 81,239,292 (+) Ensembl
RefSeq Acc Id:
NM_001427259 ⟹ NP_001414188
RefSeq Status:
VALIDATED
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 8 89,967,397 - 90,122,219 (+) NCBI
RefSeq Acc Id:
XM_008766423 ⟹ XP_008764645
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 8 89,967,351 - 90,122,219 (+) NCBI mRatBN7.2 8 81,087,158 - 81,242,022 (+) NCBI Rnor_6.0 8 87,583,649 - 87,731,271 (+) NCBI
Sequence:
AGTGACGTGCGCGCCTGGCTGGGCACTCCGCTGGGCTCTCTGGCCGGCGGGTGGAGACCGATCCGGTATCTGTCCCAGCAGGAAGCGTATCCCGGCCGCCGTCGTCTCCGGTGCTCGCTCTCGGCCGC GGCGTCGCGCTCGCCCTTCGCGCCCGCAGTCCGGCAGCCTCTCCACGGCCGCGACCCCTCGCGCACCTGCCTCGCTCGGGGAGATAGTGGGTAACCTCCTTCAAAATGGAAGATGGAAAGCCCGTTTG GGCGCCCCACCCCACAGATGGATTTCAAATGGGCAATATTGTGGATATTGGCCCTGACAGCCTAACAATTGAACCTTTGAACCAAAAAGGCAAGACATTTTTGGCTCTCATAAACCAAGTATTCCCTG CAGAAGAGGACAGCAAAAAAGATGTGGAAGATAACTGTTCACTGATGTACTTAAATGAAGCCACACTGCTCCACAATGTCAAAGTTCGGTACAGTAAAGACAGAATCTACACGTATGTGGCCAACATT CTGATTGCAGTGAATCCATACTTTGATATACCTAAGATATATTCTTCAGACACAATAAAGTCCTATCAAGGAAAATCTCTTGGGACAATGCCACCTCATGTCTTTGCCATTGCTGATAAGGCTTTTCG AGACATGAAGGTGCTCAAGATGAGCCAGTCTATCATTGTGTCTGGAGAATCAGGAGCTGGCAAAACAGAGAATACAAAGTTTGTTCTAAGATACTTGACAGAATCTTATGGAACAGGTCAAGATATTG ATGATAGAATCGTTGAAGCTAATCCACTTTTAGAAGCGTTTGGAAATGCAAAGACTGTTCGTAACAATAATAGCAGTCGATTTGGAAAATTTGTAGAAATTCATTTCAACGAGAAGAGTTCGGTTGTT GGAGGATTTGTTTCCCATTACCTTCTAGAGAAGTCTAGGATTTGTGTTCAAGGCAAAGAGGAGCGGAATTACCATATTTTTTACAGGCTGTGTGCTGGGGCTTCAGAAGACATTAGGGAGAAGCTTCA CTTGAGCTCCCCAGATAATTTTCGGTATCTAAATCGGGGCTGCACTAGGTACTTCGCCAACAAAGAAACGGACAAACAAATTTTACAGAACCGAAAAAGTCCTGAGTATGTTAAGGCAGGTTCCTTGA AGGATCCTCTGTTAGATGACCATGGAGATTTTATCAGGATGTGCACAGCCATGAAAAAAATCGGTTTGGATGATGAAGAAAAACTTGATCTATTTCGAGTCGTGGCTGGTGTCCTGCACCTTGGAAAT ATTGATTTTGAGGAAGCCGGAAGCACTTCAGGTGGCTGCAATCTGAAGAACAAATCCGCCCCCTCACTGGAGTACTGTGCTGAATTGCTGGGTTTGGACCAAGATGACCTTCGAGTCAGTTTAACCAC TAGAGTCATGCTCACCACAGCAGGGGGCACCAAAGGAACTGTTATAAAGGTCCCCCTGAAGGTGGAACAGGCAAACAGTGCTCGAGATGCTCTGGCGAAGACGGTCTATAGCCATCTCTTTGACCACG TGGTGGACAGGGTGAATCAGTGCTTTCCTTTTGAAACATCCTCTTATTTTATTGGAGTCCTGGATATTGCTGGCTTCGAGTACTTTGAGCACAACAGCTTTGAGCAGTTTTGTATCAACTATTGCAAT GAGAAACTTCAACAGTTTTTTAATGAAAGGATCCTAAAGGAGGAACAAGAACTGTATCAGAAAGAGGGCCTGGGTGTTAATGAAGTCCATTACGTGGACAATCAGGACTGCATAGATTTGATTGAAGT AAAATTAGTGGGAATCCTGGATATTCTGGATGAAGAAAATCGTCTTCCCCAGCCGAGTGACCAGCACTTTACATCCGTGGTTCACCAGAAGCACAAAGACCATTTCCGACTCACTATTCCCAGGAAAT CTAAGCTGGCAGTCCACAGAAACCTCAGAGATGACGAAGGCTTTATCATCAGGCACTTTGCAGGGGCTGTGTGCTATGAGACAACCCAGTTTGTGGAGAAAAATAATGATGCACTACATATGTCTCTT GAATCCTTGATATGTGAGTCCAGGGACAAGTTTATACGGGCGTTGTTTGAGTCATCCACAAATAACAACAAAGATACGAAACAAAAGGCTGGAAAACTTAGCTTCATCAGCGTGGGAAACAAGTTCAA GACACAATTAAATTTGCTTCTGGATAAACTTCGAAGTACTGGAGCCAGCTTCATCCGCTGCATCAAACCCAACTTAAAGATGACAAGTCACCACTTCGAAGGCGCTCAGATTCTGTCTCAACTTCAGT GTTCAGGTATGGTGTCTGTGCTGGACCTCATGCAAGGGGGTTTCCCTTCAAGAGCCTCATTTCATGAACTCTATAACATGTACAAGAAGTACATGCCAGAAAAACTCGCACGATTGGATCCACGGCTA TTTTGTAAGGCTCTTTTTAAAGCTTTGGGATTAAATGAAGTTGACTACAAGTTTGGGCTGACAAAAGTATTTTTCAGACCTGGCAAGTTTGCAGAATTTGATCAGATTATGAAGTCTGATCCTGATCA CTTAGCAGAGTTGGTGAAGAGAGTCAATTTGTGGCTAGTCTGTAGTCGCTGGAAGAAAGTTCAGTGGTGTTCACTGTCAGTCATCAAACTGAAAAACAAAATAAAATACCGAGCTGAAGCATGCATTA AAATGCAGAAGACCATCCGGATGTGGCTTTGCAAAAGAAGACACAAACCACGCATCGACGGCCTGGTTAAGGTGGGCACACTGAAGAAGCGACTCGATAAGTTCAATGAAGTCGTGAGTGCGCTGAAA GACGGAAAGCCGGAGGTGAACAGACAGATCAAAGATCTTGAAATTTCTATCGATGCTCTGATGGCCAAAATTAAGTCCACCATGATGACGAGGGAGCAGATACAGAAAGAGTATGATGCACTCGTTAA AAGCTCGGAAGATCTCCTCAGTGCGCTGCAGAAAAAGAAGCAGCAGGAGGAGGAGGCGGAGAGGCTGAGGCGCATCCAAGAGGAGATGGAAAAGGAAAGGAAGAGACGCGAAGAAGACGAACAGCGTC GGCGGAAGGAGGAGGAGGAGAGGCGGATGAAACTTGAGATGGAAGTGAAGAGAAAACAAGAAGAAGAGGAAAGGAAGAAGCGGGAAGATGATGAGAAGCGCATCCAGGCTGAGGTGGAGGCACAGCTG GCAAGACAGCGGGAAGAGGAGTCCCAGCAGCAGGCGGTCCTGGCACAGGAGTGCAGGGACAGGGAGTTGGCCCTGCGCATCGCCCAGAACGAGTCGGAGCTCATCAGTGATGAGGCTCAGGGTGACAC GGCACTCCGAAGCTCAAGTTCCTGCCCAGCAAGTTCTAAAACTAATGGAACCAGACCCCAAATGACACCGGAACAAATGGCCAAAGAAATGTCAGACATTTTGAGTAGAGGTCCTGCTGTACAAGCTA CCAAGGCTGCTGCTGGTACCAAGAAACACGATCTCAGTAAATGGAAATACGCAGAACTTCGCGATACAATCAACACTTCCTGTGACATTGAGCTCCTGGCAGCTTGCAGAGAAGAATTTCACAGGAGA CTAAAAGTGTATCATGCTTGGAAATCCAAGAACAAGAAGAGAAATACTGAAACAGAGCAGCGTGCTCCCAAGTCTGTTACTGATTATGATTTTGCACCATTTTTGAACAATTCACCTCAGCAGAACCC CGCGGCTCAGCTCCCTGCCAGGCAGCAGGAGATTGAGATGAACCGACAGCAGCGTTTCTTCCGCATCCCCTTCATCCGCCCCGCGGACCAGTACAAAGACCCACAGAACAAGAAGAAGGGCTGGTGGT ACGCCCATTTTGACGGACCATGGATTGCCCGGCAGATGGAGCTGCACCCTGACAAGCCGCCCATCCTTCTTGTAGCTGGCAAGGACGACATGGAGATGTGTGAATTGAATCTCGAGGAGACAGGTCTG ACTCGAAAGCGTGGTGCTGAGATCTTGCCCAGACAGTTTGAAGAGATCTGGGAGCGCTGTGGAGGCATCCAGTACCTGCAGAGCGCCATCGAGAGCAGGCAGGCCCGGCCCACCTACGCTACAGCCAT GCTGCAGAACCTGCTCAAGTAGACCGAAGGGTTCCAGCCTAGCCCTGACCCTCACAGGCAGGGAGGTGACCGGAAGGTTCGCCACTCCCTTGCTCCTGGTAGAAATGCCTTATGCAAAGTGAACAGAT TTTATTAATCATGGAGTTTGTTAATTTGTTCAAGGTTAATTAAGGTTGAGGTAGTGGATTCAGGACCTAAAGAAGGAAAAGCCCTGATTCCAGCAGTGACCCCCACCCCTGCTCTGTTTGGTGTTTTC TGCACCCAGACAGACAGCTGATACTTCTCGCTCTGCACACTGACCACCTTATTGCTGAGTATTCTCAAGGACAAGGCTTTTTTTTTTTTAAATTCAAAACATTTGACTTTTTAAAGAAAAGGATGTCA CAGTGCCTTTATAACGGAGATAATGAAATCTTAGCTTAATTTTGTGCAAGAATTAAAGTACTTGAATTGATTAAGGCACAGATGTGTTTGGTCTAAAGAACTCTATTTTGTCTGCTTTTTCAAAAGTC CATGGAAATAGATTTCCCCTTCTTGCAGTGTGCTTAGTGCCCTTGATCCCCAAATTCTAGAATTCTGGAAAGAGCCTTAATGTATAGAATGTCTTATGTGGAGGGAGGTGCTGGGCGTTTGCAGCTCA GACATGGGATGCTTCTCTACCAAGCTCTGTGTTGCTCTTGGAATCTCCTCTTCCTAATCCACGGTAGAGTAAAGGAAATTTGGATTTTTGGAATGACTAGAGGTATTGATATAACTTTGTTTCATTTT GGAAGGGATGCAGGGTTGAGGCGGTGTTCTATGACTCTACTGGACTGAATTCCACTATTTTTTCCACTTCATCTCAACTGCAGTCTCTCCGTTTGAACCTTGTCCATGTTATTTCACGTCACTTAAGC TGGTGTACTGCTTCGGACAGCTCTCTTGCCCCTGTCCCTCCTCTGGGTATCCAGTTTGGCCTTTGAGACATGGTAATTAGAGAGCTGCTTTGTAAACTTTGTAATCCAGAAGCCCTTGCACTTAGACA TAGTTTGTTTCATGCTGCAGGAAGCCTTTAAAACACTCCCTTTGTGTTCTGTTTAGTCCTGATCAGATGTCAGCAGCTGGGGCTAATATTTACAACTTTAATATTAGGAACTTAGAGACAAAAAATAC ATCAAGGAGTTATGTTGACACCCAAAGGAGTCTTTGTATTTGAGAATAAAAGTAGAAAGCAGAACTATTCTTCACACTCCCCTTGGTTTTTAAATACCCTGACCTTTGAAATTTCAGGATTTTTATTC CTCTTAGCTCAGTTAGGAAAATACTTCCCAGCTGATGAGATTCATGCTCAGAAGCCTCGGGCACTATTGTCAGAAGCACTCCTTTTGCAGTGTCATAGTACTGAAGTACTTACTGTTATGACATCGTG GAATGATTGTTTTTGTTAAGGGAATTAAATGGCTCTGTCTGTACTAATGATTGAAAATGTGAATGAGGTTCTTTTCTGGAGGCTGTTTTACTGCTTAGATTTACTCTCGGTTGGTCTTGTGATGGGTG ACAGAGGCGCAGTCACCGAAATAAACAACCTGTTCCTCCTCTTCCACGCTCACTTTTGATTGGTGTCTTTATTTGTGCAGGATACTGAGTAACCTTTATTTCCTAGTCAAAATGAATGTAGTCCTTGG GGAAAAAAATCCAGTGGCCTAATGGATTCTTAGTGACTTCTCAGCTTGGCACTGTTTGCTGAAGCACTTTTATGTATCTTCTAGATCTTCGAATAAGCACTAGATGAAAAATTCATCAAAAAGTGGGA ATTATGGTAATAACAGATCTTAATATTTTAAAGAATTTATAGGAACTAAACGACAGCAAAGCATTGTTGAAAGTCTTTGTGGTTTTCGACTGATAATTCTCAGTCATCTCCAACCATTTCCTTCCTAA TTGTGTCACCGAGTTGTCCTACAGTGATCTGTTTCAGATAGTCTCCTGAGTTAATTTTGCCAAGCGGGAGACCTGCCCTAATTCAGGCAGCCTTTGAGCCTCCTGCATCTCACAGCAACCAGGTCCTT CCGGGGAGACTTCAGAACATCATGTTCTGGAGCACAGCAGAAAGAGTGTTCCACAGGGCCTTGAGCCAGCTTCTCTACCATGTTTTGTGGGTTCAGATCCACCAAGGCTATGCAAGAATTTGAGGCAT CCTTATTTTAATCAGTTTAAACCAATATATTATACAAGAAGAACTAATTTCTCTAATGTTTATCAGCTCCAGTTTCTTCCACCACAGTGGTTGTACGTTTTAATAGAACACAACAACAACATCAACAA CAACATCAACAACAACATCATCAACAACAACATGATGGCAAGTGTTTCTGTGTTAATTCAGTTGAGACACAGTGGTCAAAGCCAGCAGCACAGTTAGATGTGTGTTAGTAGAGAGATAGGCTCTCAGT GAGTACAGGGATTTCTAGAGGCCTGGTGGTTCCAAAAACTTCAGCCCCTTCACTGTCATGGAGACCACCTGTGCACAGGTGTCTGAGACGAAGCAAAATAAACGAACACTAGCATGTTAAAGGTGACT AGGGAGCCCTGAACCCGACTAGGGAGCCTTAAAGGTGACTAGCGAGGGTCTCACCATGGCATATAAAAAGTCCAGTGACCCCTTTGGTTTTACAAGAAAACCTCTTAAGGCAAAACTAGGAGTTGCTT GCAAGATTTAGATAATAGAAACCACAGGCAAAATAATAACAATAGATATTTATTACATGTCATCTTTATTGATTTTTTTTCCATGCTGGGTATTGAACCCAGGGCTTCATACAGGTGAGGCTCTACCA CGGTGACACCTCCCTGGCTTTTAGTTGGCTATTTTTGGAAGAGAGTTTCACTCACAGGTTACTAAAATGGTTCTCAGGGGATTCACATATGTAGATCTTTGTCTTTCATTTTTCTTTTCTTTTTATCT TTAAAATACTTGATTTAGCAGAATAGTTATTGAACTAATCAGTCAATTAATACTGTTAATGATAATCTTACTTCTTTATATGAAAAAAGTTGTAGCAAGCCAGGAAGGTCATACAGTTTGCTCCCAGA CCATAAAAAAGATGTAAATGCCTTTGCTTTAGCCACGGAGGGAAAACAATGTTTGTCCGCTTAGCAGATCCCTGGAGACTTACAAAGGGTTGTTCCTGGACTTTTCTGTTTGTCCTTAACACCGGTAA ATAAATATTGAGTTTTAATTGGTTCCAGAAGATGCAGTAGCAGTGGAGGGGGAGAGGGCAGAGGACATTTCACAGTGAGGAGAAGGATGAGGTGTGGGAAGAGTGATAAGCATAGGGCAGAGCAGAGC CTTAGTGGAAGAAGGGAGATGCTGCAGCCTCCGAAGACTGCATTCAGTGGGGATGCAGGCACTCAGACACCCTAGACAGCCAACACTCTCAGGTCCTGGCTGAGTTTTGGGATGTATTTGCTACAGCT TAGGGGCAGAAATTAAGGTTAGTAAAGTTGGGTCGTGAGTCACCTGGCATGTAGACCTTAGCAGGTAAGAATGGTGCAGCTGAACTGGAGGCACCCAGGAAAGACCTTGGCATCTTTGATACGAGCCA TGTGCAAGGGCCAGTGGAGAGTCTGCCTGTGTCAGTGCTGCACCTTTTGATAATTTGGTCCAATTCAAATCAGCGTCTTCTTTCCCCTCTGTATGATGTAATTTTGATTCTTGGAAGTATTCCAGGAG ATAATTAGGAAAAATTAATGCACATTGAAAACTGCACAATCTTTAATCTTAATTTTCATCGAAATGGAAACTCAACGTCAAATTACAAACAGACTTATTAAACAGCCACCGTTCTTCTCACTTCTGGA AGTTTGTCTATTTGTAATTGCTAATTTTTATTCATTTCCTCAAAAGTGTGTGTCTAATACTTTCCTAAAATACTGATGTACTGGAAACTCAAATAAATTGCCGTATGTGTAGAACATA
hide sequence
RefSeq Acc Id:
XM_008766425 ⟹ XP_008764647
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 8 89,967,351 - 90,122,219 (+) NCBI mRatBN7.2 8 81,087,160 - 81,242,022 (+) NCBI Rnor_6.0 8 87,583,650 - 87,731,271 (+) NCBI
Sequence:
GTGACGTGCGCGCCTGGCTGGGCACTCCGCTGGGCTCTCTGGCCGGCGGGTGGAGACCGATCCGGTATCTGTCCCAGCAGGAAGCGTATCCCGGCCGCCGTCGTCTCCGGTGCTCGCTCTCGGCCGCG GCGTCGCGCTCGCCCTTCGCGCCCGCAGTCCGGCAGCCTCTCCACGGCCGCGACCCCTCGCGCACCTGCCTCGCTCGGGGAGATAGTGGGTAACCTCCTTCAAAATGGAAGATGGAAAGCCCGTTTGG GCGCCCCACCCCACAGATGGATTTCAAATGGGCAATATTGTGGATATTGGCCCTGACAGCCTAACAATTGAACCTTTGAACCAAAAAGGCAAGACATTTTTGGCTCTCATAAACCAAGTATTCCCTGC AGAAGAGGACAGCAAAAAAGATGTGGAAGATAACTGTTCACTGATGTACTTAAATGAAGCCACACTGCTCCACAATGTCAAAGTTCGGTACAGTAAAGACAGAATCTACACGTATGTGGCCAACATTC TGATTGCAGTGAATCCATACTTTGATATACCTAAGATATATTCTTCAGACACAATAAAGTCCTATCAAGGAAAATCTCTTGGGACAATGCCACCTCATGTCTTTGCCATTGCTGATAAGGCTTTTCGA GACATGAAGGTGCTCAAGATGAGCCAGTCTATCATTGTGTCTGGAGAATCAGGAGCTGGCAAAACAGAGAATACAAAGTTTGTTCTAAGATACTTGACAGAATCTTATGGAACAGGTCAAGATATTGA TGATAGAATCGTTGAAGCTAATCCACTTTTAGAAGCGTTTGGAAATGCAAAGACTGTTCGTAACAATAATAGCAGTCGATTTGGAAAATTTGTAGAAATTCATTTCAACGAGAAGAGTTCGGTTGTTG GAGGATTTGTTTCCCATTACCTTCTAGAGAAGTCTAGGATTTGTGTTCAAGGCAAAGAGGAGCGGAATTACCATATTTTTTACAGGCTGTGTGCTGGGGCTTCAGAAGACATTAGGGAGAAGCTTCAC TTGAGCTCCCCAGATAATTTTCGGTATCTAAATCGGGGCTGCACTAGGTACTTCGCCAACAAAGAAACGGACAAACAAATTTTACAGAACCGAAAAAGTCCTGAGTATGTTAAGGCAGGTTCCTTGAA GGATCCTCTGTTAGATGACCATGGAGATTTTATCAGGATGTGCACAGCCATGAAAAAAATCGGTTTGGATGATGAAGAAAAACTTGATCTATTTCGAGTCGTGGCTGGTGTCCTGCACCTTGGAAATA TTGATTTTGAGGAAGCCGGAAGCACTTCAGGTGGCTGCAATCTGAAGAACAAATCCGCCCCCTCACTGGAGTACTGTGCTGAATTGCTGGGTTTGGACCAAGATGACCTTCGAGTCAGTTTAACCACT AGAGTCATGCTCACCACAGCAGGGGGCACCAAAGGAACTGTTATAAAGGTCCCCCTGAAGGTGGAACAGGCAAACAGTGCTCGAGATGCTCTGGCGAAGACGGTCTATAGCCATCTCTTTGACCACGT GGTGGACAGGGTGAATCAGTGCTTTCCTTTTGAAACATCCTCTTATTTTATTGGAGTCCTGGATATTGCTGGCTTCGAGTACTTTGAGCACAACAGCTTTGAGCAGTTTTGTATCAACTATTGCAATG AGAAACTTCAACAGTTTTTTAATGAAAGGATCCTAAAGGAGGAACAAGAACTGTATCAGAAAGAGGGCCTGGGTGTTAATGAAGTCCATTACGTGGACAATCAGGACTGCATAGATTTGATTGAAGTA AAATTAGTGGGAATCCTGGATATTCTGGATGAAGAAAATCGTCTTCCCCAGCCGAGTGACCAGCACTTTACATCCGTGGTTCACCAGAAGCACAAAGACCATTTCCGACTCACTATTCCCAGGAAATC TAAGCTGGCAGTCCACAGAAACCTCAGAGATGACGAAGGCTTTATCATCAGGCACTTTGCAGGGGCTGTGTGCTATGAGACAACCCAGTTTGTGGAGAAAAATAATGATGCACTACATATGTCTCTTG AATCCTTGATATGTGAGTCCAGGGACAAGTTTATACGGGCGTTGTTTGAGTCATCCACAAATAACAACAAAGATACGAAACAAAAGGCTGGAAAACTTAGCTTCATCAGCGTGGGAAACAAGTTCAAG ACACAATTAAATTTGCTTCTGGATAAACTTCGAAGTACTGGAGCCAGCTTCATCCGCTGCATCAAACCCAACTTAAAGATGACAAGTCACCACTTCGAAGGCGCTCAGATTCTGTCTCAACTTCAGTG TTCAGGTATGGTGTCTGTGCTGGACCTCATGCAAGGGGGTTTCCCTTCAAGAGCCTCATTTCATGAACTCTATAACATGTACAAGAAGTACATGCCAGAAAAACTCGCACGATTGGATCCACGGCTAT TTTGTAAGGCTCTTTTTAAAGCTTTGGGATTAAATGAAGTTGACTACAAGTTTGGGCTGACAAAAGTATTTTTCAGACCTGGCAAGTTTGCAGAATTTGATCAGATTATGAAGTCTGATCCTGATCAC TTAGCAGAGTTGGTGAAGAGAGTCAATTTGTGGCTAGTCTGTAGTCGCTGGAAGAAAGTTCAGTGGTGTTCACTGTCAGTCATCAAACTGAAAAACAAAATAAAATACCGAGCTGAAGCATGCATTAA AATGCAGAAGACCATCCGGATGTGGCTTTGCAAAAGAAGACACAAACCACGCATCGACGGCCTGGTTAAGGTGGGCACACTGAAGAAGCGACTCGATAAGTTCAATGAAGTCGTGAGTGCGCTGAAAG ACGGAAAGCCGGAGGTGAACAGACAGATCAAAGATCTTGAAATTTCTATCGATGCTCTGATGGCCAAAATTAAGTCCACCATGATGACGAGGGAGCAGATACAGAAAGAGTATGATGCACTCGTTAAA AGCTCGGAAGATCTCCTCAGTGCGCTGCAGAAAAAGAAGCAGCAGGAGGAGGAGGCGGAGAGGCTGAGGCGCATCCAAGAGGAGATGGAAAAGGAAAGGAAGAGACGCGAAGAAGACGAACAGCGTCG GCGGAAGGAGGAGGAGGAGAGGCGGATGAAACTTGAGATGGAAGTGAAGAGAAAACAAGAAGAAGAGGAAAGGAAGAAGCGGGAAGATGATGAGAAGCGCATCCAGGCTGAGGTGGAGGCACAGCTGG CAAGACAGCGGGAAGAGGAGTCCCAGCAGCAGGCGGTCCTGGCACAGGAGTGCAGGGACAGGGAGTTGGCCCTGCGCATCGCCCAGAACGAGTCGGAGCTCATCAGTGATGAGGCTCAGGGTGACACG GCACTCCGAAGAGGTCCTGCTGTACAAGCTACCAAGGCTGCTGCTGGTACCAAGAAACACGATCTCAGTAAATGGAAATACGCAGAACTTCGCGATACAATCAACACTTCCTGTGACATTGAGCTCCT GGCAGCTTGCAGAGAAGAATTTCACAGGAGACTAAAAGTGTATCATGCTTGGAAATCCAAGAACAAGAAGAGAAATACTGAAACAGAGCAGCGTGCTCCCAAGTCTGTTACTGATTATGATTTTGCAC CATTTTTGAACAATTCACCTCAGCAGAACCCCGCGGCTCAGCTCCCTGCCAGGCAGCAGGAGATTGAGATGAACCGACAGCAGCGTTTCTTCCGCATCCCCTTCATCCGCCCCGCGGACCAGTACAAA GACCCACAGAACAAGAAGAAGGGCTGGTGGTACGCCCATTTTGACGGACCATGGATTGCCCGGCAGATGGAGCTGCACCCTGACAAGCCGCCCATCCTTCTTGTAGCTGGCAAGGACGACATGGAGAT GTGTGAATTGAATCTCGAGGAGACAGGTCTGACTCGAAAGCGTGGTGCTGAGATCTTGCCCAGACAGTTTGAAGAGATCTGGGAGCGCTGTGGAGGCATCCAGTACCTGCAGAGCGCCATCGAGAGCA GGCAGGCCCGGCCCACCTACGCTACAGCCATGCTGCAGAACCTGCTCAAGTAGACCGAAGGGTTCCAGCCTAGCCCTGACCCTCACAGGCAGGGAGGTGACCGGAAGGTTCGCCACTCCCTTGCTCCT GGTAGAAATGCCTTATGCAAAGTGAACAGATTTTATTAATCATGGAGTTTGTTAATTTGTTCAAGGTTAATTAAGGTTGAGGTAGTGGATTCAGGACCTAAAGAAGGAAAAGCCCTGATTCCAGCAGT GACCCCCACCCCTGCTCTGTTTGGTGTTTTCTGCACCCAGACAGACAGCTGATACTTCTCGCTCTGCACACTGACCACCTTATTGCTGAGTATTCTCAAGGACAAGGCTTTTTTTTTTTTAAATTCAA AACATTTGACTTTTTAAAGAAAAGGATGTCACAGTGCCTTTATAACGGAGATAATGAAATCTTAGCTTAATTTTGTGCAAGAATTAAAGTACTTGAATTGATTAAGGCACAGATGTGTTTGGTCTAAA GAACTCTATTTTGTCTGCTTTTTCAAAAGTCCATGGAAATAGATTTCCCCTTCTTGCAGTGTGCTTAGTGCCCTTGATCCCCAAATTCTAGAATTCTGGAAAGAGCCTTAATGTATAGAATGTCTTAT GTGGAGGGAGGTGCTGGGCGTTTGCAGCTCAGACATGGGATGCTTCTCTACCAAGCTCTGTGTTGCTCTTGGAATCTCCTCTTCCTAATCCACGGTAGAGTAAAGGAAATTTGGATTTTTGGAATGAC TAGAGGTATTGATATAACTTTGTTTCATTTTGGAAGGGATGCAGGGTTGAGGCGGTGTTCTATGACTCTACTGGACTGAATTCCACTATTTTTTCCACTTCATCTCAACTGCAGTCTCTCCGTTTGAA CCTTGTCCATGTTATTTCACGTCACTTAAGCTGGTGTACTGCTTCGGACAGCTCTCTTGCCCCTGTCCCTCCTCTGGGTATCCAGTTTGGCCTTTGAGACATGGTAATTAGAGAGCTGCTTTGTAAAC TTTGTAATCCAGAAGCCCTTGCACTTAGACATAGTTTGTTTCATGCTGCAGGAAGCCTTTAAAACACTCCCTTTGTGTTCTGTTTAGTCCTGATCAGATGTCAGCAGCTGGGGCTAATATTTACAACT TTAATATTAGGAACTTAGAGACAAAAAATACATCAAGGAGTTATGTTGACACCCAAAGGAGTCTTTGTATTTGAGAATAAAAGTAGAAAGCAGAACTATTCTTCACACTCCCCTTGGTTTTTAAATAC CCTGACCTTTGAAATTTCAGGATTTTTATTCCTCTTAGCTCAGTTAGGAAAATACTTCCCAGCTGATGAGATTCATGCTCAGAAGCCTCGGGCACTATTGTCAGAAGCACTCCTTTTGCAGTGTCATA GTACTGAAGTACTTACTGTTATGACATCGTGGAATGATTGTTTTTGTTAAGGGAATTAAATGGCTCTGTCTGTACTAATGATTGAAAATGTGAATGAGGTTCTTTTCTGGAGGCTGTTTTACTGCTTA GATTTACTCTCGGTTGGTCTTGTGATGGGTGACAGAGGCGCAGTCACCGAAATAAACAACCTGTTCCTCCTCTTCCACGCTCACTTTTGATTGGTGTCTTTATTTGTGCAGGATACTGAGTAACCTTT ATTTCCTAGTCAAAATGAATGTAGTCCTTGGGGAAAAAAATCCAGTGGCCTAATGGATTCTTAGTGACTTCTCAGCTTGGCACTGTTTGCTGAAGCACTTTTATGTATCTTCTAGATCTTCGAATAAG CACTAGATGAAAAATTCATCAAAAAGTGGGAATTATGGTAATAACAGATCTTAATATTTTAAAGAATTTATAGGAACTAAACGACAGCAAAGCATTGTTGAAAGTCTTTGTGGTTTTCGACTGATAAT TCTCAGTCATCTCCAACCATTTCCTTCCTAATTGTGTCACCGAGTTGTCCTACAGTGATCTGTTTCAGATAGTCTCCTGAGTTAATTTTGCCAAGCGGGAGACCTGCCCTAATTCAGGCAGCCTTTGA GCCTCCTGCATCTCACAGCAACCAGGTCCTTCCGGGGAGACTTCAGAACATCATGTTCTGGAGCACAGCAGAAAGAGTGTTCCACAGGGCCTTGAGCCAGCTTCTCTACCATGTTTTGTGGGTTCAGA TCCACCAAGGCTATGCAAGAATTTGAGGCATCCTTATTTTAATCAGTTTAAACCAATATATTATACAAGAAGAACTAATTTCTCTAATGTTTATCAGCTCCAGTTTCTTCCACCACAGTGGTTGTACG TTTTAATAGAACACAACAACAACATCAACAACAACATCAACAACAACATCATCAACAACAACATGATGGCAAGTGTTTCTGTGTTAATTCAGTTGAGACACAGTGGTCAAAGCCAGCAGCACAGTTAG ATGTGTGTTAGTAGAGAGATAGGCTCTCAGTGAGTACAGGGATTTCTAGAGGCCTGGTGGTTCCAAAAACTTCAGCCCCTTCACTGTCATGGAGACCACCTGTGCACAGGTGTCTGAGACGAAGCAAA ATAAACGAACACTAGCATGTTAAAGGTGACTAGGGAGCCCTGAACCCGACTAGGGAGCCTTAAAGGTGACTAGCGAGGGTCTCACCATGGCATATAAAAAGTCCAGTGACCCCTTTGGTTTTACAAGA AAACCTCTTAAGGCAAAACTAGGAGTTGCTTGCAAGATTTAGATAATAGAAACCACAGGCAAAATAATAACAATAGATATTTATTACATGTCATCTTTATTGATTTTTTTTCCATGCTGGGTATTGAA CCCAGGGCTTCATACAGGTGAGGCTCTACCACGGTGACACCTCCCTGGCTTTTAGTTGGCTATTTTTGGAAGAGAGTTTCACTCACAGGTTACTAAAATGGTTCTCAGGGGATTCACATATGTAGATC TTTGTCTTTCATTTTTCTTTTCTTTTTATCTTTAAAATACTTGATTTAGCAGAATAGTTATTGAACTAATCAGTCAATTAATACTGTTAATGATAATCTTACTTCTTTATATGAAAAAAGTTGTAGCA AGCCAGGAAGGTCATACAGTTTGCTCCCAGACCATAAAAAAGATGTAAATGCCTTTGCTTTAGCCACGGAGGGAAAACAATGTTTGTCCGCTTAGCAGATCCCTGGAGACTTACAAAGGGTTGTTCCT GGACTTTTCTGTTTGTCCTTAACACCGGTAAATAAATATTGAGTTTTAATTGGTTCCAGAAGATGCAGTAGCAGTGGAGGGGGAGAGGGCAGAGGACATTTCACAGTGAGGAGAAGGATGAGGTGTGG GAAGAGTGATAAGCATAGGGCAGAGCAGAGCCTTAGTGGAAGAAGGGAGATGCTGCAGCCTCCGAAGACTGCATTCAGTGGGGATGCAGGCACTCAGACACCCTAGACAGCCAACACTCTCAGGTCCT GGCTGAGTTTTGGGATGTATTTGCTACAGCTTAGGGGCAGAAATTAAGGTTAGTAAAGTTGGGTCGTGAGTCACCTGGCATGTAGACCTTAGCAGGTAAGAATGGTGCAGCTGAACTGGAGGCACCCA GGAAAGACCTTGGCATCTTTGATACGAGCCATGTGCAAGGGCCAGTGGAGAGTCTGCCTGTGTCAGTGCTGCACCTTTTGATAATTTGGTCCAATTCAAATCAGCGTCTTCTTTCCCCTCTGTATGAT GTAATTTTGATTCTTGGAAGTATTCCAGGAGATAATTAGGAAAAATTAATGCACATTGAAAACTGCACAATCTTTAATCTTAATTTTCATCGAAATGGAAACTCAACGTCAAATTACAAACAGACTTA TTAAACAGCCACCGTTCTTCTCACTTCTGGAAGTTTGTCTATTTGTAATTGCTAATTTTTATTCATTTCCTCAAAAGTGTGTGTCTAATACTTTCCTAAAATACTGATGTACTGGAAACTCAAATAAA TTGCCGTATGTGTAGAACATA
hide sequence
RefSeq Acc Id:
XM_039082536 ⟹ XP_038938464
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 8 89,967,351 - 90,122,219 (+) NCBI mRatBN7.2 8 81,087,158 - 81,242,022 (+) NCBI
RefSeq Acc Id:
XM_063265552 ⟹ XP_063121622
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 8 90,053,437 - 90,122,219 (+) NCBI
RefSeq Acc Id:
XM_063265553 ⟹ XP_063121623
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 8 90,053,437 - 90,122,219 (+) NCBI
RefSeq Acc Id:
XR_005488326
Type:
NON-CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 8 89,967,351 - 90,084,056 (+) NCBI mRatBN7.2 8 81,087,157 - 81,203,859 (+) NCBI
RefSeq Acc Id:
XR_005488327
Type:
NON-CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 8 89,967,351 - 90,084,056 (+) NCBI mRatBN7.2 8 81,087,158 - 81,203,859 (+) NCBI
RefSeq Acc Id:
XP_008764645 ⟸ XM_008766423
- Peptide Label:
isoform X1
- UniProtKB:
A0A8I6ACM8 (UniProtKB/TrEMBL), A0A8I5ZYN7 (UniProtKB/TrEMBL), A0A8I6AEW8 (UniProtKB/TrEMBL)
- Sequence:
MEDGKPVWAPHPTDGFQMGNIVDIGPDSLTIEPLNQKGKTFLALINQVFPAEEDSKKDVEDNCSLMYLNEATLLHNVKVRYSKDRIYTYVANILIAVNPYFDIPKIYSSDTIKSYQGKSLGTMPPHVF AIADKAFRDMKVLKMSQSIIVSGESGAGKTENTKFVLRYLTESYGTGQDIDDRIVEANPLLEAFGNAKTVRNNNSSRFGKFVEIHFNEKSSVVGGFVSHYLLEKSRICVQGKEERNYHIFYRLCAGAS EDIREKLHLSSPDNFRYLNRGCTRYFANKETDKQILQNRKSPEYVKAGSLKDPLLDDHGDFIRMCTAMKKIGLDDEEKLDLFRVVAGVLHLGNIDFEEAGSTSGGCNLKNKSAPSLEYCAELLGLDQD DLRVSLTTRVMLTTAGGTKGTVIKVPLKVEQANSARDALAKTVYSHLFDHVVDRVNQCFPFETSSYFIGVLDIAGFEYFEHNSFEQFCINYCNEKLQQFFNERILKEEQELYQKEGLGVNEVHYVDNQ DCIDLIEVKLVGILDILDEENRLPQPSDQHFTSVVHQKHKDHFRLTIPRKSKLAVHRNLRDDEGFIIRHFAGAVCYETTQFVEKNNDALHMSLESLICESRDKFIRALFESSTNNNKDTKQKAGKLSF ISVGNKFKTQLNLLLDKLRSTGASFIRCIKPNLKMTSHHFEGAQILSQLQCSGMVSVLDLMQGGFPSRASFHELYNMYKKYMPEKLARLDPRLFCKALFKALGLNEVDYKFGLTKVFFRPGKFAEFDQ IMKSDPDHLAELVKRVNLWLVCSRWKKVQWCSLSVIKLKNKIKYRAEACIKMQKTIRMWLCKRRHKPRIDGLVKVGTLKKRLDKFNEVVSALKDGKPEVNRQIKDLEISIDALMAKIKSTMMTREQIQ KEYDALVKSSEDLLSALQKKKQQEEEAERLRRIQEEMEKERKRREEDEQRRRKEEEERRMKLEMEVKRKQEEEERKKREDDEKRIQAEVEAQLARQREEESQQQAVLAQECRDRELALRIAQNESELI SDEAQGDTALRSSSSCPASSKTNGTRPQMTPEQMAKEMSDILSRGPAVQATKAAAGTKKHDLSKWKYAELRDTINTSCDIELLAACREEFHRRLKVYHAWKSKNKKRNTETEQRAPKSVTDYDFAPFL NNSPQQNPAAQLPARQQEIEMNRQQRFFRIPFIRPADQYKDPQNKKKGWWYAHFDGPWIARQMELHPDKPPILLVAGKDDMEMCELNLEETGLTRKRGAEILPRQFEEIWERCGGIQYLQSAIESRQA RPTYATAMLQNLLK
hide sequence
RefSeq Acc Id:
XP_008764647 ⟸ XM_008766425
- Peptide Label:
isoform X3
- UniProtKB:
A0A8I6AEW8 (UniProtKB/TrEMBL)
- Sequence:
MEDGKPVWAPHPTDGFQMGNIVDIGPDSLTIEPLNQKGKTFLALINQVFPAEEDSKKDVEDNCS LMYLNEATLLHNVKVRYSKDRIYTYVANILIAVNPYFDIPKIYSSDTIKSYQGKSLGTMPPHVFAIADKAFRDMKVLKMSQSIIVSGESGAGKTENTKFVLRYLTESYGTGQDIDDRIVEANPLLEAF GNAKTVRNNNSSRFGKFVEIHFNEKSSVVGGFVSHYLLEKSRICVQGKEERNYHIFYRLCAGASEDIREKLHLSSPDNFRYLNRGCTRYFANKETDKQILQNRKSPEYVKAGSLKDPLLDDHGDFIRM CTAMKKIGLDDEEKLDLFRVVAGVLHLGNIDFEEAGSTSGGCNLKNKSAPSLEYCAELLGLDQDDLRVSLTTRVMLTTAGGTKGTVIKVPLKVEQANSARDALAKTVYSHLFDHVVDRVNQCFPFETS SYFIGVLDIAGFEYFEHNSFEQFCINYCNEKLQQFFNERILKEEQELYQKEGLGVNEVHYVDNQDCIDLIEVKLVGILDILDEENRLPQPSDQHFTSVVHQKHKDHFRLTIPRKSKLAVHRNLRDDEG FIIRHFAGAVCYETTQFVEKNNDALHMSLESLICESRDKFIRALFESSTNNNKDTKQKAGKLSFISVGNKFKTQLNLLLDKLRSTGASFIRCIKPNLKMTSHHFEGAQILSQLQCSGMVSVLDLMQGG FPSRASFHELYNMYKKYMPEKLARLDPRLFCKALFKALGLNEVDYKFGLTKVFFRPGKFAEFDQIMKSDPDHLAELVKRVNLWLVCSRWKKVQWCSLSVIKLKNKIKYRAEACIKMQKTIRMWLCKRR HKPRIDGLVKVGTLKKRLDKFNEVVSALKDGKPEVNRQIKDLEISIDALMAKIKSTMMTREQIQKEYDALVKSSEDLLSALQKKKQQEEEAERLRRIQEEMEKERKRREEDEQRRRKEEEERRMKLEM EVKRKQEEEERKKREDDEKRIQAEVEAQLARQREEESQQQAVLAQECRDRELALRIAQNESELISDEAQGDTALRRGPAVQATKAAAGTKKHDLSKWKYAELRDTINTSCDIELLAACREEFHRRLKV YHAWKSKNKKRNTETEQRAPKSVTDYDFAPFLNNSPQQNPAAQLPARQQEIEMNRQQRFFRIPFIRPADQYKDPQNKKKGWWYAHFDGPWIARQMELHPDKPPILLVAGKDDMEMCELNLEETGLTRK RGAEILPRQFEEIWERCGGIQYLQSAIESRQARPTYATAMLQNLLK
hide sequence
Ensembl Acc Id:
ENSRNOP00000016428 ⟸ ENSRNOT00000016428
RefSeq Acc Id:
XP_038938464 ⟸ XM_039082536
- Peptide Label:
isoform X2
- UniProtKB:
D4A5I9 (UniProtKB/TrEMBL), A0A8I5ZYN7 (UniProtKB/TrEMBL), A0A8I6AEW8 (UniProtKB/TrEMBL)
Ensembl Acc Id:
ENSRNOP00000091239 ⟸ ENSRNOT00000108142
Ensembl Acc Id:
ENSRNOP00000091730 ⟸ ENSRNOT00000103299
Ensembl Acc Id:
ENSRNOP00000083134 ⟸ ENSRNOT00000120263
Ensembl Acc Id:
ENSRNOP00000077341 ⟸ ENSRNOT00000112254
Ensembl Acc Id:
ENSRNOP00000083145 ⟸ ENSRNOT00000119730
RefSeq Acc Id:
NP_001414188 ⟸ NM_001427259
- UniProtKB:
A0A8I5ZWC2 (UniProtKB/TrEMBL), A0A8I5Y7N7 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_063121622 ⟸ XM_063265552
- Peptide Label:
isoform X4
- UniProtKB:
A6I1N5 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_063121623 ⟸ XM_063265553
- Peptide Label:
isoform X5
BioCyc Gene
G2FUF-29733
BioCyc
Ensembl Genes
ENSRNOG00000011852
Ensembl, ENTREZGENE, UniProtKB/TrEMBL
Ensembl Transcript
ENSRNOT00000016428
ENTREZGENE
ENSRNOT00000016428.9
UniProtKB/TrEMBL
ENSRNOT00000103299
ENTREZGENE
ENSRNOT00000103299.1
UniProtKB/TrEMBL
ENSRNOT00000108142.1
UniProtKB/TrEMBL
ENSRNOT00000112254
ENTREZGENE
ENSRNOT00000112254.1
UniProtKB/TrEMBL
ENSRNOT00000119730.1
UniProtKB/TrEMBL
ENSRNOT00000120263
ENTREZGENE
ENSRNOT00000120263.1
UniProtKB/TrEMBL
Gene3D-CATH
1.10.10.820
UniProtKB/TrEMBL
1.20.58.530
UniProtKB/TrEMBL
2.30.30.360
UniProtKB/TrEMBL
3.30.70.1590
UniProtKB/TrEMBL
3.40.850.10
UniProtKB/TrEMBL
6.10.220.10
UniProtKB/TrEMBL
Myosin VI head, motor domain, U50 subdomain
UniProtKB/TrEMBL
InterPro
Kinesin_motor_dom_sf
UniProtKB/TrEMBL
MYO6_lever
UniProtKB/TrEMBL
Myosin-VI_CBD
UniProtKB/TrEMBL
Myosin_head_motor_dom
UniProtKB/TrEMBL
Myosin_N
UniProtKB/TrEMBL
Myosin_S1_N
UniProtKB/TrEMBL
MYSc_Myo6
UniProtKB/TrEMBL
P-loop_NTPase
UniProtKB/TrEMBL
NCBI Gene
315840
ENTREZGENE
PANTHER
MYOSIN
UniProtKB/TrEMBL
UNCONVENTIONAL MYOSIN-VI
UniProtKB/TrEMBL
Pfam
MYO6_lever
UniProtKB/TrEMBL
Myosin-VI_CBD
UniProtKB/TrEMBL
Myosin_head
UniProtKB/TrEMBL
PhenoGen
Myo6
PhenoGen
PRINTS
MYOSINHEAVY
UniProtKB/TrEMBL
PROSITE
MYOSIN_MOTOR
UniProtKB/TrEMBL
SH3_LIKE
UniProtKB/TrEMBL
RatGTEx
ENSRNOG00000011852
RatGTEx
SMART
MYSc
UniProtKB/TrEMBL
Superfamily-SCOP
SSF52540
UniProtKB/TrEMBL
UniProt
A0A8I5Y7N7
ENTREZGENE, UniProtKB/TrEMBL
A0A8I5ZWC2
ENTREZGENE, UniProtKB/TrEMBL
A0A8I5ZYN7
ENTREZGENE, UniProtKB/TrEMBL
A0A8I6ACM8
ENTREZGENE, UniProtKB/TrEMBL
A0A8I6AEW8
ENTREZGENE, UniProtKB/TrEMBL
A6I1N5
ENTREZGENE, UniProtKB/TrEMBL
D4A5I9
ENTREZGENE, UniProtKB/TrEMBL
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2008-02-28
Myo6
myosin VI
RGD1560646
similar to Myosin VI
Nomenclature updated to reflect human and mouse nomenclature
1299863
APPROVED
2007-03-14
RGD1560646
similar to Myosin VI
RGD1560646_predicted
similar to Myosin VI (predicted)
Symbol and Name updated
1299863
PROVISIONAL
2006-03-07
RGD1560646_predicted
similar to Myosin VI (predicted)
LOC315840
similar to Myosin VI
Symbol and Name status set to approved
1299863
APPROVED
2006-02-09
LOC315840
similar to Myosin VI
Symbol and Name status set to provisional
70820
PROVISIONAL